These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cognitive impairment and structural brain damage in benign multiple sclerosis. Rovaris M; Riccitelli G; Judica E; Possa F; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Mattioli F; Martinelli V; Comi G; Filippi M Neurology; 2008 Nov; 71(19):1521-6. PubMed ID: 18815387 [TBL] [Abstract][Full Text] [Related]
9. Anatomical and functional differences between the Paced Auditory Serial Addition Test and the Symbol Digit Modalities Test. Forn C; Belenguer A; Belloch V; Sanjuan A; Parcet MA; Avila C J Clin Exp Neuropsychol; 2011 Jan; 33(1):42-50. PubMed ID: 20552497 [TBL] [Abstract][Full Text] [Related]
10. A longitudinal fMRI study of the paced auditory serial addition task. Cardinal KS; Wilson SM; Giesser BS; Drain AE; Sicotte NL Mult Scler; 2008 May; 14(4):465-71. PubMed ID: 18208900 [TBL] [Abstract][Full Text] [Related]
11. Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis. Ranjeva JP; Audoin B; Au Duong MV; Confort-Gouny S; Malikova I; Viout P; Soulier E; Pelletier J; Cozzone PJ J Neurol Sci; 2006 Jun; 245(1-2):161-7. PubMed ID: 16631206 [TBL] [Abstract][Full Text] [Related]
12. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms. Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. Morrow SA; O'Connor PW; Polman CH; Goodman AD; Kappos L; Lublin FD; Rudick RA; Jurgensen S; Paes D; Forrestal F; Benedict RH Mult Scler; 2010 Nov; 16(11):1385-92. PubMed ID: 20739335 [TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G; Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262 [TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis. Woolmore J; Stone M; Holley S; Jenkinson P; Ike A; Jones P; Fryer A; Strange R; Stephens R; Langdon D; Hawkins C Mult Scler; 2008 Mar; 14(2):177-82. PubMed ID: 17942526 [TBL] [Abstract][Full Text] [Related]
19. Task-load manipulation in the Symbol Digit Modalities Test: an alternative measure of information processing speed. Forn C; Ripollés P; Cruz-Gómez AJ; Belenguer A; González-Torre JA; Avila C Brain Cogn; 2013 Jul; 82(2):152-60. PubMed ID: 23660436 [TBL] [Abstract][Full Text] [Related]
20. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]